ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change

Journal of Experimental Botany

Volumn 64, Issue 14, 2013, Pages 4361-4374

  Montané, Marie Hélène ^a,b,c   Menand, Benoît ^a,b,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CNRS   (France)

^c DIF   (France)

Author keywords

Arabidopsis; ATP competitive mTOR kinase inhibitors; Cell size; Differentiation; Lotus; Meristem; Millet; Nicotiana; Rice; Root growth; Root hairs; Target of rapamycin

Indexed keywords

(5-(2,4-BIS((3S)-3-METHYLMORPHOLIN-4-YL)PYRIDO(2,3-D)PYRIMIDIN-7-YL)-2-METHOXYPHENYL)METHANOL; 9-(6-AMINOPYRIDIN-3-YL)-1-(3-(TRIFLUOROMETHYL)PHENYL)BENZO(H)(1,6)NAPHTHYRIDIN-2(1H)-ONE; (5 (2,4 BIS((3S) 3 METHYLMORPHOLIN 4 YL)PYRIDO(2,3 D)PYRIMIDIN 7 YL) 2 METHOXYPHENYL)METHANOL; 1 [4 [1 (1,4 DIOXASPIRO[4.5]DEC 8 YL) 4 (8 OXA 3 AZABICYCLO[3.2.1]OCT 3 YL) 1H PYRAZOLO[3,4 D]PYRIMIDIN 6 YL]PHENYL] 3 METHYLUREA; 9 (6 AMINOPYRIDIN 3 YL) 1 (3 (TRIFLUOROMETHYL)PHENYL)BENZO(H)(1,6)NAPHTHYRIDIN 2(1H) ONE; ADENOSINE TRIPHOSPHATE; ARABIDOPSIS PROTEIN; CARBANILAMIDE DERIVATIVE; MORPHOLINE DERIVATIVE; NAPHTHYRIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ARABIDOPSIS; ARTICLE; ATP-COMPETITIVE MTOR KINASE INHIBITORS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CYTOLOGY; DIFFERENTIATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE DOSAGE; GROWTH, DEVELOPMENT AND AGING; HAPLOINSUFFICIENCY; HUMAN; LOTUS; MERISTEM; METABOLISM; MILLET; MORPHOGENESIS; NICOTIANA; PHENOTYPE; PLANT DEVELOPMENT; RICE; ROOT GROWTH; ROOT HAIRS; TARGET OF RAPAMYCIN.;

ARABIDOPSIS; ATP-COMPETITIVE MTOR KINASE INHIBITORS; CELL SIZE; DIFFERENTIATION; LOTUS; MERISTEM; MILLET; NICOTIANA; RICE; ROOT GROWTH; ROOT HAIRS; TARGET OF RAPAMYCIN.;

ADENOSINE TRIPHOSPHATE; ARABIDOPSIS; ARABIDOPSIS PROTEINS; BODY PATTERNING; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE DOSAGE; HAPLOINSUFFICIENCY; HUMANS; MERISTEM; MORPHOLINES; NAPHTHYRIDINES; PHENOTYPE; PHENYLUREA COMPOUNDS; PLANT DEVELOPMENT; PROTEIN KINASE INHIBITORS; PYRAZOLES; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84887960910     PISSN: 00220957     EISSN: 14602431     Source Type: Journal    
DOI: 10.1093/jxb/ert242     Document Type: Article

References (67)

1. Amiard S, Charbonnel C, Allain E., Depeiges A, White CI, Gallego ME 2010. Distinct roles of the ATR kinase and the Mre11-Rad50-Nbs1 complex in the maintenance of chromosomal stability in Arabidopsis. Plant Cell 22, 3020-3033.
2. Bach S, Knockaert M, Reinhardt J., et al 2005. Roscovitine targets, protein kinases and pyridoxal kinase. Journal of Biological Chemistry 280, 31208-31219.
3. Bain J, Plater L, Elliott M., Shpiro N, Hastie CJ, McLauchlan H, Klevernic I., Arthur JS, Alessi DR, Cohen P. 2007. The selectivity of protein kinase inhibitors: a further update. Biochemistry Journal 408, 297-315.
4. Calabrese EJ, Blain RB 2009. Hormesis and plant biology. Environmental Pollution 157, 42-48.
5. Caldana C, Li Y, Leisse A., Zhang Y, Bartholomaeus L, Fernie A.R., Willmitzer L., Giavalisco P. 2012. Systemic analysis of inducible target of rapamycin mutants reveal a general metabolic switch controlling growth in Arabidopsis thaliana. The Plant Journal 73, 897-909.
6. Chresta CM, Davies BR, Hickson I, et al 2010. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Research 70, 288-298.
7. Colon-Carmona A., You R, Haimovitch-Gal T, Doerner P. 1999. Technical advance: spatio-temporal analysis of mitotic activity with a labile cyclin-GUS fusion protein. The Plant Journal 20, 503-508.
8. Dello Ioio R., Linhares FS, Scacchi E, Casamitjana-Martinez E, Heidstra R., Costantino P, Sabatini S. 2007. Cytokinins determine Arabidopsis root-meristem size by controlling cell differentiation. Current Biology 17, 678-682.
9. Deprost D, Yao L, Sormani R., Moreau M, Leterreux G, Nicolai M., Bedu M, Robaglia C, Meyer C. 2007. The Arabidopsis TOR kinase links plant growth, yield, stress resistance and mRNA translation. EMBO Reports 8, 864-870.
10. Dobrenel T, Marchive C, Sormani R., Moreau M, Mozzo M, Montane M.H., Menand B., Robaglia C, Meyer C. 2011. Regulation of plant growth and metabolism by the TOR kinase. Biochemical Society Transactions 39, 477-481.
11. Dolan L, Davies J. 2004. Cell expansion in roots. Current Opinion in Plant Biology 7, 33-39.
12. Dowling RJ, Topisirovic I, Fonseca B.D., Sonenberg N. 2010. Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochimica et Biophysica Acta 1804, 433-439.
13. Estelle MA, Somerville C. 1987. Auxin-resistant mutants of Arabidopsis thaliana with an altered morphology. Molecular Genetics & Genomics 206, 200-206.
14. Fan QW, Knight ZA, Goldenberg D.D., Yu W., Mostov KE, Stokoe D, Shokat KM, Weiss WA 2006. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9, 341-349.
15. Fieldman ME, Shokat KM 2011. New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor kinase domain inhibitors (TORKinibs). Current Topics in Microbiology and Immunology 347, 241-262.
16. Finlay MR, Griffin RJ 2012. Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family. Bioorganic & Medicinal Chemistry Letters 22, 5352-5359.
17. Garcia V, Salanoubat M, Choisne N., Tissier A. 2000. An ATM homologue from Arabidopsis thaliana: complete genomic organisation and expression analysis. Nucleic Acids Research 28, 1692-1699.
18. Garcia-Martinez J.M., Moran J, Clarke R.G., Gray A., Cosulich SC, Chresta CM, Alessi DR 2009. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochemistry Journal 421, 29-42.
19. Gerard M, Deleersnijder A, Demeulemeester J., Debyser Z, Baekelandt V. 2011. Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration. Molecular Neurobiology 44, 13-27.
20. Gharbi SI, Zvelebil MJ, Shuttleworth S.J., Hancox T., Saghir N, Timms JF, Waterfield MD 2007. Exploring the specificity of the PI3K family inhibitor LY294002. Biochemistry Journal 404, 15-21.
21. Giaever G, Shoemaker DD, Jones T.W., Liang H., Winzeler EA, Astromoff A, Davis RW 1999. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nature Genetics 21, 278-283.
22. Golding SE, Rosenberg E, Valerie N., et al 2009. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin AKT and ERK prosurvival signaling, and inhibits migration and invasion. Molecular Cancer Therapeutics 8, 2894-2902.
23. Guertin DA, Sabatini DM 2009. The pharmacology of mTOR inhibition. Science Signaling 2, p e24.
24. Jiang H, Fan D, Zhou G., Li X, Deng H. 2010. Phosphatidylinositol 3-kinase inhibitor (LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo. Journal of Experimental & Clinical Cancer Research 29, 34.
25. Kreuz K, Tommasini R, Martinoia E. 1996. Old enzymes for a new job (herbicide detoxification in plants). Plant Physiology 111, 349-353.
26. Kung C, Shokat KM 2005. Small-molecule kinase-inhibitor target assessment. ChemBioChem 6, 523-526.
27. Laplante M, Sabatini DM 2012. mTOR signaling in growth control and disease. Cell 149, 274-293.
28. Lee Y, Bak G, Choi Y., Chuang WI, Cho HT, Lee Y. 2008. Roles of phosphatidylinositol 3-kinase in root hair growth. Plant Physiology 147, 624-635.
29. Leiber RM, John F, Verhertbruggen Y., Diet A, Knox JP, Ringli C. 2010. The TOR pathway modulates the structure of cell walls in Arabidopsis. Plant Cell 22, 1898-1908.
30. Li Y, Yang DQ 2010. The ATM inhibitor KU-55933supp resses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt. Molecular Cancer Therapeutics 9, 113-125.
31. Lianguzova MS, Chuykin IA, Nordheim A, Pospelov VA 2007. Phosphoinositide 3-kinase inhibitor LY294002 but not serum withdrawal suppresses proliferation of murine embryonic stem cells. Cell Biology International 31, 330-337.
32. Liu Q, Chang JW, Wang J, et al 2010. Discovery of 1-(4-(4- propionylpiperazin-1-yl)-3-(trifuoromethyl)phenyl)-9-(quinolin-3-yl)benz o[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer. Journal of Medicinal Chemistry 53, 7146-7155.
33. Liu Q, Kirubakaran S, Hur W., et al 2012a. Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics. Journal of Biological Chemistry 287, 9742-9752.
34. Liu Q, Ren T, Fresques T., Oppliger W, Niles BJ, Hur W, Sabatini D.M., Hall MN, Powers T, Gray NS 2012b. Selective ATP-competitive inhibitors of TOR suppress rapamycin-insensitive function of TORC2 in Saccharomyces cerevisiae. ACS Chemical Biology 7, 982-987.
35. Liu Q, Wang J, Kang S.A., Thoreen CC, Hur W, Ahmed T, Sabatini D.M., Gray NS 2011. Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifuoromethyl)phenyl) benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer. Journal of Medicinal Chemistry 54, 1473-1480.
36. Liu X, Yang JM, Zhang S.S., Liu XY, Liu DX 2010. Induction of cell cycle arrest at G1 and S phases and cAMP-dependent differentiation in C6 glioma by low concentration of cycloheximide. BMC Cancer 10, 684.
37. Loewith R, Hall MN 2011. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 189, 1177-1201.
38. Lum PY, Armour CD, Stepaniants S.B., et al 2004. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116, 121-137.
39. Meijer L, Borgne A, Mulner O., Chong JP, Blow JJ, Inagaki N, Inagaki M., Delcros JG, Moulinoux JP 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. European Journal of Biochemistry 243, 527-536.
40. Menand B, Desnos T, Nussaume L., Berger F, Bouchez D, Meyer C., Robaglia C. 2002. Expression and disruption of the Arabidopsis TOR (target of rapamycin) gene. Proceedings of the National Academy of Sciences, USA 99, 6422-6427.
41. Menand B, Meyer C, Robaglia C. 2004. Plant growth and the TOR pathway. Current Topics in Microbiology and Immunology 279, 97-113.
42. Menand B, Yi K, Jouannic S., Hoffmann L, Ryan E, Linstead P., Schaefer D, Dolan L. 2007. An ancient mechanism controls the development of cells with a rooting function in land plants. Science 316, 1477-1480.
43. Moon SW, Chung EJ, Jung S.A., Lee JH 2009. PDGF stimulation of Muller cell proliferation: contributions of c-JNK and the PI3K/Akt pathway. Biochemical and Biophysical Research Communications 388, 167-171.
44. Muraro D, Byrne H, King J., Bennett M. 2013. The role of auxin and cytokinin signalling in specifying the root architecture of Arabidopsis thaliana. Journal of Theoretical Biology 317, 71-86.
45. Perilli S, Sabatini S. 2010. Analysis of root meristem size development. Methods in Molecular Biology 655, 177-187.
46. Planchais S, Glab N, Trehin C., Perennes C, Bureau JM, Meijer L, Bergounioux C. 1997. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2cell suspension. The Plant Journal 12, 191-202.
47. Raynaud FI, Eccles S, Clarke P.A., et al 2007. Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Research 67, 5840-5850.
48. Ren M, Qiu S, Venglat P., Xiang D, Feng L, Selvaraj G., Datla R. 2011. Target of rapamycin regulates development and ribosomal RNA expression through kinase domain in Arabidopsis. Plant Physiology 155, 1367-1382.
49. Ren M, Venglat P, Qiu S., et al 2012. Target of rapamycin signaling regulates metabolism, growth, and life span in Arabidopsis. Plant Cell 24, 4850-4874.
50. Ricaud L, Proux C, Renou J.P., Pichon O., Fochesato S, Ortet P, Montane MH 2007. ATM-mediated transcriptional and developmental responses to γ-rays in Arabidopsis. PLoS One 2, e430.
51. Robaglia C, Thomas M, Meyer C. 2012. Sensing nutrient and energy status by SnRK1 and TOR kinases. Current Opinion in Plant Biology 15, 301-307.
52. Santoni V, Bellini C, Caboche M. 1994. Use of two-dimensional protein-pattern analysis for the characterization of Arabidopsis mutants. Planta 192, 557-566.
53. Schepetilnikov M, Kobayashi K, Geldreich A., Caranta C, Robaglia C, Keller M., Ryabova LA 2011. Viral factor TAV recruits TOR/S6K1 signalling to activate reinitiation after long ORF translation. EMBO Journal 30, 1343-1356.
54. Schneider-Poetsch T., Ju J, Eyler D.E., Dang Y., Bhat S, Merrick WC, Green R, Shen B., Liu JO 2010. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nature Chemical Biology 6, 209-217.
55. Serfontein J, Nisbet RE, Howe C.J., de Vries PJ. 2010. Evolution of the TSC1/TSC2-TOR signaling pathway. Science Signaling 3, ra49.
56. Soltis D, Soltis P, Endress P, Chase M. 2005. Phylogeny and evolution of angiosperms. Sunderland: Sinauer Associates.
57. Sormani R, Yao L, Menand B., Ennar N, Lecampion C, Meyer C., Robaglia C. 2007. Saccharomyces cerevisiae FKBP12 binds Arabidopsis thaliana TOR and its expression in plants leads to rapamycin susceptibility. BMC Plant Biolog 7, 26.
58. Syed F, Sanganee HJ, Bahl A, Bayat A. 2013. Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity. Journal of Investigative Dermatology 133, 1340-1350.
59. Templeton GW, Moorhead GB 2005. The phosphoinositide-3-OH-kinase-related kinases of Arabidopsis thaliana. EMBO Reports 6, 723-728.
60. Thoreen CC, Kang SA, Chang J.W., Liu Q., Zhang J, Gao Y, Reichling L.J., Sim T., Sabatini DM, Gray NS 2009. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. Journal of Biological Chemistry 284, 8023-8032.
61. Ubeda-Tomas S., Federici F, Casimiro I., Beemster GT, Bhalerao R, Swarup R, Doerner P., Haseloff J, Bennett MJ 2009. Gibberellin signaling in the endodermis controls Arabidopsis root meristem size. Current Biology 19, 1194-1199.
62. Wallace A, Ashcroft RT, Leo M.W., Wallace GA 1970. Effect of cycloheximide, gamma irradiation, and phosphorus deficiency on root pressure exudation in tobacco. Plant Physiology 45, 300-303.
63. Xiong Y, Sheen J. 2012. Rapamycin and glucose-target of rapamycin (TOR) protein signaling in plants. Journal of Biological Chemistry 287, 2836-2842.
64. Xiong Y, McCormack M, Li L., Hall Q, Xiang C, Sheen J. 2013. Glucose-TOR signalling reprograms the transcriptome and activates meristems. Nature 496, 181-186.
65. Yu K, Shi C, Toral-Barza L, et al 2010. Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Research 70, 621-631.
66. Yu K, Toral-Barza L, Shi C., Zhang WG, Lucas J, Shor B, Kim J., Verheijen J, Curran K, Malwitz DJ et al. 2009. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Research 69, 6232-6240.
67. Zhang YJ, Duan Y, Zheng XF 2011. Targeting the mTOR kinase domain: the second generation of mTOR inhibitors. Drug Discovery Today 16, 325-331.